IFS Advisors’s AbbVie ABBV Stock Holding History

IFS Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.3K	Hold	200	–	–	0.02%	59
2026 Q1	$43.5K	Hold	200	–	–	0.02%	60
2025 Q4	$45.7K	Hold	200	–	–	0.02%	50
2025 Q3	$46.3K	Hold	200	–	–	0.03%	49
2025 Q2	$37.1K	Sell	200 -300	-60%	-$55.8K	0.03%	44
2025 Q1	$105K	Hold	500	–	–	0.09%	24
2024 Q4	$88.8K	Buy	500 +300	+150%	+$55.2K	0.07%	25
2024 Q3	$39.5K	Hold	200	–	–	0.03%	34
2024 Q2	$34.3K	Hold	200	–	–	0.03%	33
2024 Q1	$36.4K	Buy	+200	New	+$34.5K	0.03%	34

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

IFS Advisors's ABBV Position: Q2 2026 in Review

IFS Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 200 shares worth $50.3K. The position accounts for 0.02% of the portfolio, ranked #59.

IFS Advisors first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $105K in Q1 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

IFS Advisors held 200 shares of AbbVie worth $50.3K as of Q2 2026.
IFS Advisors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.02% of IFS Advisors's portfolio in Q2 2026, its #59 holding.
IFS Advisors first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
IFS Advisors's AbbVie position peaked at $105K in Q1 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on IFS Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.